Filing Details

Accession Number:
0001104659-21-153685
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-27 20:58:07
Reporting Period:
2021-12-22
Accepted Time:
2021-12-27 20:58:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Iveric Bio Inc. ISEE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277478 Glenn Sblendorio C/O Iveric Bio, Inc.
5 Penn Plaza, Suite 2372
New York, NY 10001
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-22 22,163 $1.45 361,296 No 4 M Direct
Common Stock Disposition 2021-12-22 22,163 $16.50 339,133 No 4 S Direct
Common Stock Acquisiton 2021-12-23 22,608 $1.45 361,741 No 4 M Direct
Common Stock Acquisiton 2021-12-23 8,476 $2.94 370,217 No 4 M Direct
Common Stock Disposition 2021-12-23 31,084 $16.96 339,133 No 4 S Direct
Common Stock Disposition 2021-12-23 20,000 $0.00 319,133 No 4 G Direct
Common Stock Disposition 2021-12-23 20,000 $0.00 299,133 No 4 G Direct
Common Stock Disposition 2021-12-23 20,000 $0.00 279,133 No 4 G Direct
Common Stock Acquisiton 2021-12-27 5,229 $1.45 284,362 No 4 M Direct
Common Stock Disposition 2021-12-27 5,229 $16.64 279,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 G Direct
No 4 G Direct
No 4 G Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-12-22 22,163 $0.00 22,163 $1.45
Common Stock Stock Option (Right to Buy) Disposition 2021-12-23 22,608 $0.00 22,608 $1.45
Common Stock Stock Option (Right to Buy) Disposition 2021-12-23 8,476 $0.00 8,476 $2.94
Common Stock Stock Option (Right to Buy) Disposition 2021-12-27 5,229 $0.00 5,229 $1.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
161,337 2028-12-11 No 4 M Direct
138,729 2028-12-11 No 4 M Direct
391,524 2027-12-18 No 4 M Direct
133,500 2028-12-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect By trust for family member 1
Common Stock 20,000 Indirect By trust for family member 2
Common Stock 20,000 Indirect By trust for family member 3
Footnotes
  1. The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021.
  2. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.60 per share on December 22, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
  3. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $17.09 per share on December 23, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
  4. On December 23, 2021, the Reporting Person gifted a total of 60,000 shares of Registrant's common stock to three trusts of which the Reporting Person's immediate family members are the sole trustees and sole beneficiaries.
  5. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  6. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.85 per share on December 27, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
  7. This option was granted on December 12, 2018 and vests as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date, and (3) such stock options shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change of control in the Registrant.
  8. This option was granted on December 19, 2017 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.